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Drug addiction is a chronic, relapsing disorder, which is caused
bymany factors including genetic, epigenetic, environmental, and
drug-related (Robison and Nestler, 2011). Loss of control over
drug intake and compulsion for drug taking are the most charac-
teristic features of addiction (Koob and Volkow, 2010). Although
many individuals are exposed to substances of abuse, only subsets
enter the addicted state. However, if the addicted state devel-
ops, it persists for life, suggesting that the underlying molecular
changes in the brain are long-lasting. The present research topic
was selected to highlight several new insights about genetic and
drug-related factors that contribute to drug-induced neuroplastic
changes.
Because dopaminergic cells play a pivotal role in the rewarding
action of drugs of abuse, they were the starting point for the study
of drug-induced synaptic alterations. Rodriguez Parkitna and
Engblom (2012) added new insights to our knowledge about the
synaptic plasticity of dopaminergic cells in the ventral tegmen-
tal area focusing on NMDA and AMPA receptor functions. For
this, knockout mice with selective deletion of the NR1 sub-
unit of the NMDA receptors were used. They examined NMDA
receptor plasticity and burst firing activity, and found that this
plays an important role in reward learning. Furthermore, they
show NMDA receptors on dopaminergic cells are involved in
drug-induced associative learning and in recall of drug-associated
experiences.
Withdrawal is an unbalanced state characterized by increased
stress, anxiety, and depression. During chronic drug consump-
tion and withdrawal, the brain stress response system becomes
dysregulated. The expression of several neuropeptides, includ-
ing corticotropin releasing factor (CRF), neuropeptide Y, and
dynorphin are stress-related. Furthermore, these neuropeptides
are involved in the modulation of negative emotional states asso-
ciated with drug addiction (Boutrel and De Lecea, 2008; Allen
et al., 2011; Bruijnzeel, 2012).
Yadid et al. in their focused review (Yadid et al., 2012)
concentrated on the neuroadaptive processes occurring during
withdrawal. Evidence shows that endogenous opioid peptides
β-endorphin, enkephalin, and dynorphin play an important
role in substance reinforcement. β-endorphin and the neuros-
teroid dehydroepiandrosterone (DHEA) both modulate mood
and drug addiction, and these modulatory functions are linked
with each other. Application of exogenous DHEA-S (phospho-
rylated DHEA) into the nucleus accumbens elevated the level
of extracellular β-endorphin. Thus, modulation of DHEA level
in the brain may regulate extracellular β-endorphin levels which
consequently controls stress coping including mood fluctuations.
Together, these processes end up regulating the craving for drugs
of abuse.
Dempsey and Grisel (2012) in their research paper exam-
ined the role of β-endorphin in the development of locomotor
sensitization to repeated chronic alcohol exposure. They found
that mice lacking β-endorphin did not develop locomotor sen-
sitization to alcohol. These findings support the notion that
β-endorphin modulates the locomotor effect induced by alco-
hol consumption and contributes to the neuroadaptive changes
associated with chronic use.
Haass-Koffler and Bartlett (2012) in their review discussed the
role of CRF in alleviation and maintenance of synaptic plastic-
ity in the ventral tegmental area and amygdala. CRF facilitates the
molecular changes induced by drugs of abuse like enhancement of
glutamate-mediated excitation and reduction of GABA-mediated
inhibition. Stress induces plastic changes in the limbic system
that are thought to trigger the development of chronic anxi-
ety and loss of control over limited drug use. Regulating stress
processes by modulating the function of the CRF system may
offer a possible new therapeutic approach in the treatment of
relapse.
Besides the stress response, the Dynorphin/κ-opioid receptor
(DYN/KOR) system is also highly dysregulated during chronic,
excessive alcohol consumption and both contribute to the neg-
ative emotional state experienced during withdrawal (Koob and
Volkow, 2010). Excessive alcohol consumption leads to the adap-
tation of the DYN/KOR system at the pharmacological, tran-
scriptional, and epigenetic levels. Various key brain regions
are involved via activation of different signaling pathways, like
CREB/FosB/BDNF, which contribute to altered downstream
events. These changes can lead to escalated alcohol use, anxiety
like behaviors, and sensitization following abstinence, which are
the most common consequences of alcohol dependence (Sirohi
et al., 2012).
Feduccia et al. (2012) in their review added new insights to the
function of nicotinic acetylcholine receptors (nAChR) in alcohol
and nicotine addiction. The nAChRs are ligand-gated ion chan-
nels which are wildly distributed in the brain and play a crucial
role in synaptic neurotransmission (Mao et al., 2011). Both alco-
hol and nicotine are able to activate neuronal nAChRs. Activation
of nAChRs by nicotine and alcohol facilitates and maintains
long-term potentiation, long-term depression, and also struc-
tural changes in the hippocampus, amygdala, and mesolimbic
dopaminergic system. Chronic nicotine treatment leads to up-
regulation of nAChRs, which serves as a compensatory response
to excessive receptor stimulation and is a main contributor to the
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development of nicotine dependence. Several studies showed that
chronic alcohol treatment induces the same processes and also
that activation of nAChR function can reduce voluntary alcohol
consumption.
Recently, a growing body of evidence shows that epigenetic
mechanisms play a pivotal role in long-lasting changes in gene
expression by regulation of transcriptional potential (McClung
and Nestler, 2003; Chao and Nestler, 2004). Madsen et al. (2012)
summarized our knowledge about the epigenetic modulation of
gene expression induced by drugs of abuse. Self-administration
of drugs of abuse induces transcriptional changes in the cell that
represent a key mechanism affecting reward-related learning and
further drug-related behaviors. Thus, voluntary drug intake con-
trolled by a fine equilibrium of opposingmolecular regulators can
facilitate or inhibit compulsive drug use. This research has opened
up new therapeutic strategies by modulation of transcriptional
regulatory functions.
In her focused review, Kovacs (2012) summarized the
role of neuroinflammatory processes in the development
of chronic drug-induced molecular changes in the brain.
Activation of microglia cells plays a pivotal role in drug-
induced morphological, molecular, and physiological changes.
These alterations involve release of proinflammatory cytokines,
remodeling of synaptic functions, excitotoxic neurochemi-
cal changes, and phagocytic activity. Targeting microglia can
serve as a potential new treatment strategy in addiction
treatment.
Nylander and Roman (2012) provided a summary about the
consequences of early-life stress. How changes early in life influ-
ence the function of peptide networks, like endogenous opioid
peptides, oxytocin, and vasopressin later in adulthood. The results
summarized in this review indicate that there is a strong associ-
ation between early-life rearing conditions, opioids, and ethanol
consumption. The effects of ethanol and also the treatment effi-
cacy of opioid antagonists later in life are both dependent on
early-life experiences.
Taken together, this research topic delivered new visions to our
knowledge about the neuroplastic changes in chronic escalated
drug consumption and in the following withdrawal.
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